HANK & LIN'S GROUP
The past is prologue and the future is scintillating
1994
1. Al-Tikriti MS, Baldwin RM, Zea-Ponce Y, Sybirska E, Zoghbi SS, Laruelle M, Malison RT, Kung HF, Kessler RM, Charney DS, et al. Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor. Nucl Med Biol. 1994 Feb;21(2):179-88. doi: 10.1016/0969-8051(94)90007-8. PMID: 9234281.
2. Burris KD, Filtz TM, Chumpradit S, Kung MP, Foulon C, Hensler JG, Kung HF, Molinoff PB. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle. J Pharmacol Exp Ther. 1994 Feb;268(2):935-42. PMID: 8114008.
3. Chumpradit S, Kung MP, Vessotskie J, Foulon C, Mu M, Kung HF. Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors. J Med Chem. 1994 Nov 25;37(24):4245-50. doi: 10.1021/jm00050a021. PMID: 7990123.
4. Francesconi LC, Yang YY, Kung MP, Zhang XX, Billings JJ, Guo YZ, Kung HF. Technetium-99m N,N'-bis(2-mercapto-2-methylpropyl)-2-aminobenzylamine: technetium-99m complexes of a novel bis(aminoethanethiol) ligand. J Med Chem. 1994 Sep 30;37(20):3282-8. doi: 10.1021/jm00046a012. PMID: 7932555.
5. Garner SE, Kung MP, Foulon C, Chumpradit S, Kung HF. [125I](S)-trans-7-OH-PIPAT: a potential spect imaging agent for sigma binding sites. Life Sci. 1994;54(9):593-603. doi: 10.1016/0024-3205(94)00865-5. PMID: 8114613.
6. Goodman MM, Kung MP, Kabalka GW, Kung HF, Switzer R. Synthesis and characterization of radioiodinated N-(3-iodopropen-1-yl)-2 beta-carbomethoxy-3 beta-(4-chlorophenyl)tropanes: potential dopamine reuptake site imaging agents. J Med Chem. 1994 May 13;37(10):1535-42. doi: 10.1021/jm00036a020. PMID: 8182712.
7. Kung HF, Kung MP, Clarke W, Maayani S, Zhuang ZP. A potential 5-HT1A receptor antagonist: p-MPPI. Life Sci. 1994;55(19):1459-62. doi: 10.1016/0024-3205(94)00686-5. PMID: 7968212.
8. Kung MP, Canney DJ, Frederick D, Zhuang Z, Billings JJ, Kung HF. Binding of 125I-iodovinyltetrabenazine to CNS vesicular monoamine transport sites. Synapse. 1994 Nov;18(3):225-32. doi: 10.1002/syn.890180308. PMID: 7855735.
9. Kung MP, Chumpradit S, Frederick D, Garner S, Burris KD, Molinoff PB, Kung HF. Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec;350(6):611-7. doi: 10.1007/BF00169365. PMID: 7708118.
10. Kung MP, Zhuang ZP, Frederick D, Kung HF. In vivo binding of [123I]4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)- p-iodobenzamido-]ethyl-piperazine, p-MPPI, to 5-HT1A receptors in rat brain. Synapse. 1994 Dec;18(4):359-66. doi: 10.1002/syn.890180412. PMID: 7886629.
11. Laruelle M, van Dyck C, Abi-Dargham A, Zea-Ponce Y, Zoghbi SS, Charney DS, Baldwin RM, Hoffer PB, Kung HF, Innis RB. Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects. J Nucl Med. 1994 May;35(5):743-54. PMID: 8176454.
12. Laruelle M, al-Tikriti MS, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Charney DS, Hoffer PB, Kung HF, Innis RB. In vivo quantification of dopamine D2 receptor parameters in nonhuman primates with [123I]iodobenzofuran and single photon emission computerized tomography. Eur J Pharmacol. 1994 Sep 22;263(1-2):39-51. doi: 10.1016/0014-2999(94)90521-5. PMID: 7821360.
13. Shao L, Billings J, Pfeiffer N, Kung HF. Concentration recovery for SPECT CNS dopamine-receptor studies for monkeys. Med Phys. 1994 May;21(5):675-81. doi: 10.1118/1.597321. PMID: 7935203.
14. Zhuang ZP, Kung MP, Chumpradit S, Mu M, Kung HF. Derivatives of 4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl-p-iodobenzamido)ethyl]pipera zine (p-MPPI) as 5-HT1A ligands. J Med Chem. 1994 Dec 23;37(26):4572-5. doi: 10.1021/jm00052a018. PMID: 7799409.
15. Zhuang ZP, Kung MP, Kung HF. Synthesis and evaluation of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand. J Med Chem. 1994 May 13;37(10):1406-7. doi: 10.1021/jm00036a003. PMID: 8182697.
16. Zouakia A, Chalon S, Kung HF, Dognon AM, Saliba E, Besnard JC, Guilloteau D. Radioiodinated tracers for the evaluation of dopamine receptors in the neonatal rat brain after hypoxic-ischemic injury. Eur J Nucl Med. 1994 Jun;21(6):488-92. doi: 10.1007/BF00173033. PMID: 8082661.
17. Boudreau, R. J., S. C. Jackels, S. M. N. Efange, and H. F. Kung. "Accurate Prediction of the Structure Tc-99m Complexes using Molecular Mechanics Based Calculations." In JOURNAL OF NUCLEAR MEDICINE, vol. 35, no. 5, pp. P243-P243. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1994.
18. Canney, D. J., M-P. Kung, Y-Z. Guo, and H. F. Kung. "Amino/amido-tetrabenazine analogs as potential monoamine transporter ligands." Journal of Labelled Compounds and Radiopharmaceuticals 35 (1994): 515-516.
19. Chumpradit, S., M. P. Kung, S. Garner, and H. F. Kung. "trans-7-OH-IPAT: a potential sigma receptor imaging agent for SPECT." Journal of Labelled Compounds and Radiopharmaceuticals 35 (1994): 444-446.
20. Chumpradit, S., M. P. Kung, C. Foulon, and H. F. Kung. "(R) trans-7-OH-PIPAT: a potential D3 dopamine receptor imaging agent for SPECT." Journal of Labelled Compounds and Radiopharmaceuticals 35 (1994): 473-475.
21. CHUMPRADIT, S., MP KUNG, M. MU, J. VESSOTSKIE, and HF KUNG. "IODINATED TETRALINS AS D3 DOPAMINE-RECEPTOR LIGANDS." In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, vol. 208, pp. 176-MEDI. 1155 16TH ST, NW, WASHINGTON, DC 20036: AMER CHEMICAL SOC, 1994.
22. Goodman, M. M., G. W. Kabalka, M. P. Kung, H. F. Kung, and M. A. Meyer. "Synthesis of N-3-[18 F] fluoropropyl-2β-carbomethoxy-3β-(4-chlorophenyl) tropane: a high affinity neuroligand to map dopamine reuptake sites by PET." Journal of Labelled Compounds and Radiopharmaceuticals 35 (1994): 488-490.
23. Kung, H. F., S. Chumpradit, M. P. Kung, J. Vessotskie, W. McElgin, D. Mozley, and D. Frederick. "I-123 5-OH-PIPAT-A NEW DOPAMINE D3 AND D2H RECEPTOR-LIGAND FOR SPECT IMAGING." In JOURNAL OF NUCLEAR MEDICINE, vol. 35, no. 5, pp. P246-P246. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1994.
24. Kung, H. F., Z. P. Zhuang, M. P. Kung, P. D. Mozley, H. J. Kim, W. McElgin, and D. Frederick. "[I-123] P-MPPI-A POTENTIAL 5-HT1A RECEPTOR ANTAGONIST FOR SPECT IMAGING." In JOURNAL OF NUCLEAR MEDICINE, vol. 35, no. 5, pp. P93-P93. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1994.
25. MEEGALLA, SK, MP KUNG, M. MU, DJ CANNEY, and HF KUNG. "NEW TBZ DERIVATIVES FOR VESICULAR MONOAMINE TRANSPORT (VMAT) SITES." In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, vol. 208, pp. 203-MEDI. 1155 16TH ST, NW, WASHINGTON, DC 20036: AMER CHEMICAL SOC, 1994.
26. Ohmomo, Y., C. Tanaka, M. Hirata, Y. Magata, A. Yokoyama, and H. F. Kung. "Radioiodinated benzamide derivative: a new SPECT radiopharmaceutical for monoamine oxidase-B." Journal of Labelled Compounds and Radiopharmaceuticals 35 (1994): 236-238.
27. Shiue, C. Y., G. G. Shiue, Z. P. Zhuang, M. P. Kung, and H. F. Kung. "SYNTHESIS OF NO-CARRIER-ADDED 4-(2'-METHOXY-PHENYL)-1-[2'-(N-2''-PYRIDINYL-P-[F18] FLUORO-BENZAMIDO-] ETHYLPIPERAZINE (2B) AS A POTENTIAL 5-HT1A RECEPTOR-LIGAND FOR PET STUDIES." In JOURNAL OF NUCLEAR MEDICINE, vol. 35, no. 5, pp. P252-P252. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1994.
28. Westera, G., A. Buck, G. K. von Schulthess, and H. F. Kung. "A simplified preparation and metabolite analysis of a new D2 SPECT ligand:[123-I]-IBF." Journal of Labelled Compounds and Radiopharmaceuticals 35 (1994): 469-470.
29. ZHUANG, ZP, MP KUNG, M. MU, D. FREDERICK, and HF KUNG. "SYNTHESES AND SAR OF P-MPPI-A SERIES OF POTENT 5-HT (1A) ANTAGONISTS." In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, vol. 208, pp. 179-MEDI. 1155 16TH ST, NW, WASHINGTON, DC 20036: AMER CHEMICAL SOC, 1994.
1993
1. Billings JJ, Guo YZ, Kung MP, Kung HF. Localization of IBF as a D-2 dopamine receptor imaging agent in nonhuman primates. Eur J Nucl Med. 1993 Dec;20(12):1146-53. doi: 10.1007/BF00171012. PMID: 8299649.
2. Canney DJ, Billings J, Francesconi LC, Guo YZ, Haggerty BS, Rheingold AL, Kung HF. Dicarboxylate diamide dimercaptide (N2S2) technetium-99m complexes: synthesis and biological evaluation as potential renal radiopharmaceuticals. J Med Chem. 1993 Apr 16;36(8):1032-40. doi: 10.1021/jm00060a011. PMID: 8478903.
3. Canney, D.J.; Billings, J.J.; Guo, Y.Z.; Francesconi, L.C.; Kung, H.F. Synthesis and biological evaluation of dicarboxylate technetium-99m diamide-dimercaptide complexes as potential renal imaging agents. Journal of Labelled Compounds and Radiopharmaceuticals 32: 59-61,1993
4. Canney, Daniel J., Yu-Zhi Guo, Mei-Ping T. Kung and Hank F. Kung. “Synthesis and preliminary evaluation of an iodovinyl-tetrabenazine analog as a marker for the vesicular monoamine transporter.” Journal of Labelled Compounds and Radiopharmaceuticals 33 (1993): 355-368.
5. Chumpradit S, Kung MP, Billings J, Mach R, Kung HF. Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT. J Med Chem. 1993 Jan 22;36(2):221-8. doi: 10.1021/jm00054a005. PMID: 8093734.
6. Chumpradit S, Kung MP, Kung HF. Synthesis and optical resolution of (R)- and (S)-trans-7-Hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin: a new D3 dopamine receptor ligand. J Med Chem. 1993 Dec 24;36(26):4308-12. doi: 10.1021/jm00078a021. PMID: 8277513.
7. Mozley PD, Zhu X, Kung HF, Selikson MH, Hickey J, Galloway S, Pfieffer N, Alavi A. The dosimetry of iodine-123-labeled TISCH: a SPECT imaging agent for the D1 dopamine receptor. J Nucl Med. 1993 Feb;34(2):208-13. PMID: 8429338.
8. Foulon C, Kung MP, Kung HF. Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand. J Med Chem. 1993 May 14;36(10):1499-500. doi: 10.1021/jm00062a025. PMID: 8098771.
9. Francesconi, L. C., G. Graczyk, S. Wehrli, S. N. Shaikh, D. McClinton, S. Liu, J. Zubieta, and H. F. Kung. "Synthesis and characterization of neutral MVO (M= technetium, rhenium) amine-thiol complexes containing a pendant phenylpiperidine group." Inorganic Chemistry 32, no. 14 (1993): 3114-3124.
10. Guo YZ, Kung MP, Cheng H, Pfeiffer N, Mozley D, Kung HF. A simplified method for quantitation of iodine-123 iodobenzamide in human plasma: a technical note. Eur J Nucl Med. 1993 May;20(5):373-8. doi: 10.1007/BF00208994. PMID: 8519255.
11. Hank F Kung, Iodinated Dopamine D1 and D2 Receptor Imaging Agents for SPECT. “Nuclear Imaging in Drug Discovery, Development, and Approval”, 227-243, 1993, Birkhäuser Boston.
12. Kung MP, Kung HF, Chumpradit S, Foulon C. In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A. Eur J Pharmacol. 1993 Apr 22;235(1):165-6. doi: 10.1016/0014-2999(93)90839-a. PMID: 8519278.
13. Mozley PD, Zhu X, Kung HF, Selikson MH, Hickey J, Galloway S, Pfieffer N, Alavi A. The dosimetry of iodine-123-labeled TISCH: a SPECT imaging agent for the D1 dopamine receptor. J Nucl Med. 1993 Feb;34(2):208-13. PMID: 8429338.
14. Mozley PD, Stubbs JB, Kung HF, Selikson MH, Stabin MG, Alavi A. Biodistribution and dosimetry of iodine-123-IBF: a potent radioligand for imaging the D2 dopamine receptor. J Nucl Med. 1993 Nov;34(11):1910-7. PMID: 8229233.
15. Verhoeff NP, Sokole EB, Stabin M, Hengst D, Kung HF, Van Royen EA, Janssen AG. Dosimetry of iodine-123 iodobenzamide in healthy volunteers. Eur J Nucl Med. 1993 Sep;20(9):747-52. doi: 10.1007/BF00180903. PMID: 8223767.
16. Zhuang ZP, Kung MP, Kung HF. Synthesis of (R,S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)amino]tetral in (trans-8-OH-PIPAT): a new 5-HT1A receptor ligand. J Med Chem. 1993 Oct 15;36(21):3161-5. doi: 10.1021/jm00073a016. PMID: 8230102.
17. Boli, Liu, Meng Zhaoxing, and H. F. Kung. "Quantitative study of the structure-stability of TcO (III)-complexes based on CNDO/2 method." Journal of Labelled Compounds and Radiopharmaceuticals 32, no. 1-12 (1993): 21-23.
18. A BUCK, G WESTERA, HF KUNG, C ALBANI, GK VONSCHULTHESS. 1ST EXPERIENCE WITH THE NEW D2 LIGAND [I-123] IBE, COMPARISON WITH [I-123] IBZM. JOURNAL OF NUCLEAR MEDICINE, 34(5)P196-197,1993
19. Canney, D., Y-Z. Guo, H. F. Kung, and M. P. Kung. "Monaamine storage site imaging agent for SPECT: iodinated tetrabenazine." Journal of Labelled Compounds and Radiopharmaceuticals 32, no. 1-12 (1993): 199-200.
20. Chumpradit, S., H. F. Kung, and M. P. Kung. "Fluorinated and iodinated dopamine agents (FIDA): D2 imaging agents for PET and SPECT." Journal of Labelled Compounds and Radiopharmaceuticals 32, no. 1-12 (1993): 223-224.
21. CHUMPRADIT, S., J. BILLINGS, MP KUNG, and HF KUNG. "5-IODO-3-TYRAMINE AS A POTENTIAL METABOLIC TRACER FOR DOPAMINE." In JOURNAL OF NUCLEAR MEDICINE, vol. 34, no. 5, pp. P235-P235. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1993.
22. Goodman, M. M., M. P. Kung, G. W. Kabalka, HF KUNG, and MA MEYER. "RADIOIODINATED 2-BETA-CARBOISOPROPOXY-3-BETA-(4-CHLOROPHENYL)-8-(3EIODOPROPEN-2-YL) NORTROPANE-SYNTHESIS OF A POTENTIAL RADIOLIGAND FOR MAPPING DOPAMINE REUPTAKE SITES BY SPECT." In JOURNAL OF NUCLEAR MEDICINE, vol. 34, no. 5, pp. P235-P235. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1993.
23. Hirata, M., Magata, Y., Saji, H., Yokoyama, A., Ohmomo, Y., Tanaka, C., & Kung, H.F. (1993). Radioiodinated clorgyline derivative for mapping MAO-A activity in brain with SPECT. Journal of Labelled Compounds and Radiopharmaceuticals, 32(1-12), 204-206.
24. Kim, H. J., J. S. Karp, H. F. Kung, and P. D. Mozley. "QUANTITATIVE EFFECTS OF A COUNT RATE-DEPENDENT WIENER FILTER ON IMAGE QUALITY-A BASAL GANGLIA PHANTOM STUDY SIMULATING [I-123] DYNAMIC SPECT IMAGING." In JOURNAL OF NUCLEAR MEDICINE, vol. 34, no. 5, pp. P190-P190. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1993.
25. Kim, H. J., J. S. Karp, H. F. Kung, P. D. Mozley, and A. Alavi. "COLLIMATOR AND FILTER SELECTION-SIMULATING TC-99M CEREBRAL PERFUSION STUDIES WITH A 3-DIMENSIONAL HOFFMAN BRAIN PHANTOM." In JOURNAL OF NUCLEAR MEDICINE, vol. 34, no. 5, pp. P195-P195. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1993.
26. KUNG, HF, MP KUNG, C. FOULON, S. CHUMPRADIT, P. MCGONIGLE, J. BILLINGS, and S. GARNER. "D3 LIGANDS FOR SPECT IMAGING-FANTASY OR REALITY." In JOURNAL OF NUCLEAR MEDICINE, vol. 34, no. 5, pp. P132-P132. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1993.
27. Kung, M. P., S. Chumpradit, C. Foulon, S. Garner, and HF KUNG. "IODINATED TETRALINS-POTENTIAL SIGMA-LIGANDS FOR SPECT IMAGING." In JOURNAL OF NUCLEAR MEDICINE, vol. 34, no. 5, pp. P89-P89. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1993.
28. MOZLEY, PD, HF KUNG, HJ KIM, and RE GUR. "THE CEREBRAL DISTRIBUTION OF D2-DOPAMINE RECEPTORS IN HEALTHY-MEN-MRI BASED ANALYSIS OF SPECT IMAGES ACQUIRED WITH I-123 IBF." In JOURNAL OF NUCLEAR MEDICINE, vol. 34, no. 5, pp. P198-P198. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1993.
29. OYA, S., YZ GUO, MP KUNG, G. ROMANIELLO, S. GARNER, and HF KUNG. "NOVEL TC-99M COMPLEXES BASED ON NEW N2S2 AND N2SO LIGANDS." In JOURNAL OF NUCLEAR MEDICINE, vol. 34, no. 5, pp. P135-P135. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1993.
30. Stubbs, J. B., M. G. Stabin, P. D. Mozley, M. H. Selikson, H. F. Kung, and A. Alavi. "THE DOSIMETRY OF I-123 IBF-AN IMAGING LIGAND OF THE D2 DOPAMINE RECEPTOR." In JOURNAL OF NUCLEAR MEDICINE, vol. 34, no. 5, pp. P158-P158. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1993.
31. ZHUANG, ZP, MP KUNG, and HF KUNG. "8-OH-PIPAT-A POTENTIAL 5-HT1A LIGAND." In JOURNAL OF NUCLEAR MEDICINE, vol. 34, no. 5, pp. P89-P89. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316: SOC NUCLEAR MEDICINE INC, 1993.
1992
1. Billings JJ, Kung MP, Chumpradit S, Mozley D, Alavi A, Kung HF. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor. J Neurochem. 1992 Jan;58(1):227-36. doi: 10.1111/j.1471-4159.1992.tb09300.x. PMID: 1530770.
2. Chumpradit S, Kung MP, Panyachotipun C, Prapansiri V, Foulon C, Brooks BP, Szabo SA, Tejani-Butt S, Frazer A, Kung HF. Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sites. J Med Chem. 1992 Nov 13;35(23):4492-7. doi: 10.1021/jm00101a029. PMID: 1447750.
3. Christy S John, Lynn C Francesconi, Hank F Kung, Suzanne Wehrli, Grazyna Graczyk, Patrick Carroll. Synthesis and characterization of neutral oxotechnetium (V) bisaminoethanethiol complexes: potential brain imaging agents. Polyhedron, 11(10)1145-1155,1992
4. Efange SM, Dutta AK, Michelson RH, Kung HF, Thomas JR, Billings J, Boudreau RJ. Radioiodinated 2-hydroxy-3-(4-iodophenyl)-1-(4-phenylpiperidinyl)propane: potential radiotracer for mapping central cholinergic innervation in vitro. Int J Rad Appl Instrum B. 1992 Apr;19(3):337-48. doi: 10.1016/0883-2897(92)90119-j. PMID: 1629023.
5. Kung MP, Chumpradit S, Billings J, Kung H. 4-Iodotomoxetine: a novel ligand for serotonin uptake sites. Life Sci. 1992;51(2):95-106. doi: 10.1016/0024-3205(92)90002-7. PMID: 1614281.
6. Ohmomo Y, Francesconi L, Kung MP, Kung HF. New conformationally restricted 99mTc N2S2 complexes as myocardial perfusion imaging agents. J Med Chem. 1992 Jan;35(1):157-62. doi: 10.1021/jm00079a021. PMID: 1732524.
7. Seibyl JP, Woods SW, Zoghbi SS, Baldwin RM, Dey HM, Goddard AW, Zea-Ponce Y, Zubal G, Germine M, Smith EO, … Kung HF，et al. Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZM. J Nucl Med. 1992 Nov;33(11):1964-71. PMID: 1432157.
8. Broich, K.; Alavi, A.; Harris, J.; Mozley, D.; Billings, J.; Kung, H. SPECT IMAGING OF DOPAMINE D2 RECEPTORS WITH 123I-IBZM IN NORMAL CONTROLS AND AFTER DIFFERENT DOSES OF HALOPERIDOL, Clinical Neuropharmacology: Volume 15 - Issue Part B - p 105B，1992
9. Broich, Karl, Jeffrey Billings, Ling Shao, Abass Alavi, and Hank Kung. "In vivo displacement of CNS D1 and D2 receptor binding measured by spect imaging." International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology 19, no. 1 (1992): 138.
10. Karl Broich, Jeffrey Billings, Ling Shao, Abass Alavi, Hank Kung. In vivo displacement of CNS D1 and D2 receptor binding measured by spect imaging, International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology. 19(1)138,1992
11. Hank F Kung, Mei-Ping Kung, Sumalee Chumpradit, Jeffrey Billings, Abass Alavi. Radioiodinated D1 and D2 dopamine receptor ligands, International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology. 19(1)115-116, 1992
1991
1. Chumpradit S, Kung MP, Billings JJ, Kung HF. Synthesis and resolution of (+-)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro- 1H-3- benzazepine (TISCH): a high affinity and selective iodinated ligand for CNS D1 dopamine receptor. J Med Chem. 1991 Mar;34(3):877-83. doi: 10.1021/jm00107a002. Erratum in: J Med Chem 1991 Dec;34(12):3405. PMID: 1825848.
2. Kung HF. Overview of radiopharmaceuticals for diagnosis of central nervous disorders. Crit Rev Clin Lab Sci. 1991;28(4):269-86. doi: 10.3109/10408369109106866. PMID: 1930679.
3. Kung MP, Liu BL, Yang YY, Billings JJ, Kung HF. A kit formulation for preparation of iodine-123-IBZM: a new CNS D-2 dopamine receptor imaging agent. J Nucl Med. 1991 Feb;32(2):339-42. PMID: 1825113.
4. John CS, Kung MP, Billings J, Kung HF. Preparation, radiolabeling and biodistribution of a new class of bisaminothiol (BAT) ligands as possible imaging agents. Int J Rad Appl Instrum B. 1991;18(5):551-6. doi: 10.1016/0883-2897(91)90117-4. PMID: 1917525.
5. Mach RH, Kung HF, Jungwiwattanaporn P, Guo YZ. Synthesis and biodistribution of a new class of 99mTc-labeled fatty acid analogs for myocardial imaging. Int J Rad Appl Instrum B. 1991;18(2):215-26. doi: 10.1016/0883-2897(91)90082-v. PMID: 2026498.
6. Mach RH, Kung HF. Mass spectral analysis diaminodithiol ligands used for the complexation of technetium‐99m. Organic mass spectrometry. 26(5)528-530,1991
7. McPherson, D. W., E. Lisic, FF KNAPP, K. R. Ambrose, C. R. Lambert, MP KUNG, and H. Kung. "SYNTHESIS AND EVALUATION OF 2 RADIOIODINATED IODOALKENYL-SUBSTITUTED SPIROPERIDOL ANALOGS." NUC COMPACT-EUROPEAN-AMERICAN COMMUNICATIONS IN NUCLEAR MEDICINE 22, no. 3 (1991): 92-98.
8. Lynn C Francesconi, Bo-Li Liu, Jeffrey J Billings, Patrick J Carroll, Grazyna Graczyk, Hank F Kung. Synthesis, characterization and solid state structure of a neutral gallium (III) amino thiolate complex: a potential radiopharmaceutical for PET imaging. J. Chem. Soc., Chem. Commun., 1991, 94-95
1990
1. Efange, S. M. N., H. F. Kung, Deborah C. Mash, M. Jabir, J. Billings, J. Pablo, A. Dutta, and A. Freshler. "Pargyline‐Sensitive selective accumulation of a radiolabeled MPTP analog in the primate cerebral cortex and basal ganglia." Synapse 5, no. 3 (1990): 207-212.
2. Filtz TM, Chumpradit S, Kung HF, Molinoff PB. Synthesis and applications of an aldehyde-containing analogue of SCH-23390. Bioconjug Chem. 1990 Nov-Dec;1(6):394-9. doi: 10.1021/bc00006a005. PMID: 2151561.
3. Kostyniak PJ, Nakeeb SM, Schopp EM, Maccubbin AE, John EK, Green MA, Kung HF. Acute toxicity and mutagenicity of the copper complex of pyruvaldehyde-bis (N-4-methylthiosemicarbazone), Cu-PTSM. J Appl Toxicol. 1990 Dec;10(6):417-21. doi: 10.1002/jat.2550100607. PMID: 2084181.
4. Kung HF. New technetium 99m-labeled brain perfusion imaging agents. Semin Nucl Med. 1990 Apr;20(2):150-8. doi: 10.1016/s0001-2998(05)80167-9. PMID: 2184522.
5. Kung HF, Ohmomo Y, Kung MP. Current and future radiopharmaceuticals for brain imaging with single photon emission computed tomography. Semin Nucl Med. 1990 Oct;20(4):290-302. doi: 10.1016/s0001-2998(05)80235-1. PMID: 2237449.
6. Kung HF. Radiopharmaceuticals for CNS receptor imaging with SPECT. Int J Rad Appl Instrum B. 1990;17(1):85-92. doi: 10.1016/0883-2897(90)90012-p. PMID: 2155190.
7. Kung HF, Alavi A, Chang W, Kung MP, Keyes JW Jr, Velchik MG, Billings J, Pan S, Noto R, Rausch, et al. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans. J Nucl Med. 1990 May;31(5):573-9. PMID: 2140408.
8. Kung HF, Liu BL, Mankoff D, Kung MP, Billings JJ, Francesconi L, Alavi A. A new myocardial imaging agent: synthesis, characterization, and biodistribution of gallium-68-BAT-TECH. J Nucl Med. 1990 Oct;31(10):1635-40. PMID: 2213185.
9. Kung HF, Liu BL, Wei Y, Pan S. Quantitative study of the structure-stability relationship of TcvO(III) complexes. Int J Rad Appl Instrum A. 1990;41(8):773-81. doi: 10.1016/0883-2889(90)90026-d. PMID: 2172189.
10. Kung MP, Kung HF, Billings J, Yang Y, Murphy RA, Alavi A. The characterization of IBF as a new selective dopamine D-2 receptor imaging agent. J Nucl Med. 1990 May;31(5):648-54. PMID: 2140409.
11. Murphy RA, Kung HF, Kung MP, Billings J. Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents. J Med Chem. 1990 Jan;33(1):171-8. doi: 10.1021/jm00163a029. PMID: 2136916.
12. Shih WJ, Cottrill CM, Coupal JJ, O'Connor W, Kung HF, Ryo UY. Iodine-123-HIPDM lung imaging in pulmonary vein-banded pulmonary hypertension. J Nucl Med. 1990 May;31(5):668-73. PMID: 2341903.
13. Shih WJ, Coupal JJ, Magoun S, Pulmano C, Kung HF, Ryo YY. I-123 HIPDM planar brain images demonstrating crossed cerebellar diaschisis. Clin Nucl Med. 1990 Jan;15(1):34-7. doi: 10.1097/00003072-199001000-00011. PMID: 2306896.
14. Shih WJ, Dekosky ST, Coupal JJ, Simmons G, Pulmano C, Kung HF, Ryo UY, Clark DB. I-123 hydroxyiodobenzyl propanediamine (HIPDM) cerebral blood flow imaging demonstrating transtentorial diaschisis. Clin Nucl Med. 1990 Sep;15(9):623-9. doi: 10.1097/00003072-199009000-00008. PMID: 2208883.
15. Wei Y, Liu BL, Kung HF. Quantitative study of the structure-stability relationship of Tc complexes. Int J Rad Appl Instrum A. 1990;41(8):763-71. doi: 10.1016/0883-2889(90)90025-c. PMID: 2172188.
16. Zhang Xiaoxiang, Liu Boli, Jin Yutai, & Kung, H.F. (1990). Development of 99mTc-ECD as a new brain imaging agent: Pt 1. Journal of Isotopes, 3(2), 73-78.
17. Kung, H F, Pan, S, Liu, B -L, and Wei, Y. 1990. "Quantitative study of the structure-stability relationship of Tc sup v O(III) complexes." United Kingdom. https://doi.org/10.1016/0883-2889(90)90026-D.
18. Biersack, H.J., Kung, H.F., Coenen, H.H., Stoecklin, G., Kropp, J., Buescher, K., & Gruenwald, F. (1990). Imaging of D22dopamine receptors using iodine-123 labelled IBZM. Switzerland: Editiones
19. Chumpradit, S., M. P. Kung, and H. F. Kung. New derivatives of SCH-23390 as CNS D-1 dopamine receptor ligands. No. DOE/ER/60968--1. 1990.
20. Francesconi, L. C., S. Efange, C. John, and H. F. Kung. Structural analysis of Tc v ON 2 S 2 complexes. No. DOE/ER/60968--1. 1990.
21. Francesconi, L. C., B. L. Liu, J. Billings, M. P. Kung, A. Alavi, and H. F. Kung. Synthesis and characterization of a new gallium N 2 S 2 complex for myocardial imaging. No. DOE/ER/60968--1. 1990.
22. John, C. S., C. H. Paik, R. C. Reba, Y. Ohmomo, and H. F. Kung. A new versatile method for the synthesis of aminethiol ligands. No. DOE/ER/60968--1. 1990.
23. Kung, H.F. (1990). Radioactive iodinated imaging agents. United States: American Chemical Society.
24. Kung, H.F. (1990). Technetium chemistry. United States: American Chemical Society.
25. Kung, H. K., B. L. Liu, L. C. Francesconi, Y. Ohmomo, J. Billings, and M. P. Kung. Metal-N 2 S 2 complexes in radiopharmaceutical development. No. DOE/ER/60968--1. 1990.
26. Kung, H F, Pan, S, Liu, B -L, and Wei, Y. 1990. "Quantitative study of the structure-stability relationship of Tc sup v O(III) complexes." United Kingdom. https://doi.org/10.1016/0883-2889(90)90026-D.
27. Luedtke, Robert R., Melissa Bush, Robert H. Mach, Richard E. Ehrenkaufer, Hank F. Kung, and Perry B. Molinoff. "Antibodies with high affinity for spiroperidol—II. cross reactivity with iodobenzamide and domperidone." Molecular immunology 27, no. 7 (1990): 667-677.
28. Mach, R. H., and H. F. Kung. Mass Spectral analysis of N2S2 ligands used for complexation of Tc-99m. No. DOE/ER/60968--1. 1990.
